420 related articles for article (PubMed ID: 20948989)
1. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
2. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells.
Mao A; Liu Y; Wang Y; Zhao Q; Zhou X; Sun C; Di C; Si J; Gan L; Zhang H
Tumour Biol; 2016 Apr; 37(4):4831-40. PubMed ID: 26520443
[TBL] [Abstract][Full Text] [Related]
3. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
Hu J; Fang Y; Cao Y; Qin R; Chen Q
Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
[TBL] [Abstract][Full Text] [Related]
4. MiR-449a Sponges Cyclin D1 Expression and Suppresses Phosphorylation of Retinoblastoma Protein against Osteosarcoma.
Sun Z; Gao M; Li Z; Hao Q; Li L
Crit Rev Eukaryot Gene Expr; 2021; 31(3):5-19. PubMed ID: 34369711
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
[TBL] [Abstract][Full Text] [Related]
6. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
[TBL] [Abstract][Full Text] [Related]
7. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
Noonan EJ; Place RF; Pookot D; Basak S; Whitson JM; Hirata H; Giardina C; Dahiya R
Oncogene; 2009 Apr; 28(14):1714-24. PubMed ID: 19252524
[TBL] [Abstract][Full Text] [Related]
8. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles for p107 and p130 in Rb-independent cellular senescence.
Lehmann BD; Brooks AM; Paine MS; Chappell WH; McCubrey JA; Terrian DM
Cell Cycle; 2008 May; 7(9):1262-8. PubMed ID: 18418057
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1.
Long B; Li N; Xu XX; Li XX; Xu XJ; Liu JY; Wu ZH
Biochem Biophys Res Commun; 2018 Oct; 505(2):561-568. PubMed ID: 30278884
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
Zhang Z; Shao L; Wang Y; Luo X
Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
[TBL] [Abstract][Full Text] [Related]
14. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.
Bandi N; Vassella E
Mol Cancer; 2011 May; 10():55. PubMed ID: 21575235
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503.
Qi H; Wen B; Wu Q; Cheng W; Lou J; Wei J; Huang J; Yao X; Weng G
Biomed Pharmacother; 2018 Jun; 102():326-332. PubMed ID: 29571017
[TBL] [Abstract][Full Text] [Related]
16. miR-29 and miR-30 regulate B-Myb expression during cellular senescence.
Martinez I; Cazalla D; Almstead LL; Steitz JA; DiMaio D
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):522-7. PubMed ID: 21187425
[TBL] [Abstract][Full Text] [Related]
17. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
Xia H; Long J; Zhang R; Yang X; Ma Z
Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
[TBL] [Abstract][Full Text] [Related]
18. MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
Cai K; Wang Y; Bao X
J Exp Clin Cancer Res; 2011 Aug; 30(1):73. PubMed ID: 21819631
[TBL] [Abstract][Full Text] [Related]
19. The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
Shekhar R; Priyanka P; Kumar P; Ghosh T; Khan MM; Nagarajan P; Saxena S
J Biol Chem; 2019 Mar; 294(12):4381-4400. PubMed ID: 30679313
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.
Shu J; Xia Z; Li L; Liang ET; Slipek N; Shen D; Foo J; Subramanian S; Steer CJ
RNA Biol; 2012 Oct; 9(10):1275-87. PubMed ID: 22995834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
